Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.
about
Physical Properties of Eu2+-Containing Cryptates as Contrast Agents for Ultrahigh-Field Magnetic Resonance ImagingTailoring encodable lanthanide-binding tags as MRI contrast agentsDesign of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersDesign of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkersiGPCR-drug: a web server for predicting interaction between GPCRs and drugs in cellular networkingiEzy-drug: a web server for identifying the interaction between enzymes and drugs in cellular networkingCharacterizing Focused-Ultrasound Mediated Drug Delivery to the Heterogeneous Primate Brain In Vivo with Acoustic Monitoring.Protein Nanospheres: Synergistic Nanoplatform-Based Probes for Multimodality Imaging.Hyperfine coupling constants on inner-sphere water molecules of Gd(III)-based MRI contrast agents.Enhanced MRI relaxivity of Gd(3+) -based contrast agents geometrically confined within porous nanoconstructs.MRI contrast agents: basic chemistry and safety.Discrete nanomolecular polyhedral borane scaffold supporting multiple gadolinium(III) complexes as a high performance MRI contrast agentGadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of Gd³⁺ to the glycosaminoglycan heparin.Is macrocycle a synonym for kinetic inertness in Gd(III) Complexes? Effect of coordinating and noncoordinating substituents on inertness and relaxivity of Gd(III) chelates with DO3A-like ligands.Development of a novel lipidic nanoparticle probe using liposomal encapsulated Gd₂O₃-DEG for molecular MRI.Hyperfine interactions in a gadolinium-based MRI contrast agent: high-frequency modulations from ab initio simulations.Human whole-blood (1)H2O longitudinal relaxation with normal and high-relaxivity contrast reagents: influence of trans-cell-membrane water exchangeBifunctional Gd(III) and Tb(III) chelates based on a pyridine-bis(iminodiacetate) platform, suitable optical probes and contrast agents for magnetic resonance imaging.Entrapment of a neutral Tm(III)-based complex with two inner-sphere coordinated water molecules into PEG-stabilized vesicles: towards an alternative strategy to develop high-performance LipoCEST contrast agents for MR imaging.Relaxivity enhancement of aquated Tris(β-diketonate)gadolinium(III) chelates by confinement within ultrashort single-walled carbon nanotubes.Use of oral gadobenate dimeglumine to visualise the oesophagus during magnetic resonance angiography in patients with atrial fibrillation prior to catheter ablation.Bifunctional chelates optimized for molecular MRIA bis(pyridine N-oxide) analogue of DOTA: relaxometric properties of the Gd(III) complex and efficient sensitization of visible and NIR-emitting lanthanide(III) cations including Pr(III) and Ho(III).Characterisation and application of ultra-high spin clusters as magnetic resonance relaxation agents.Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.Design and Control of Nanoconfinement to Achieve Magnetic Resonance Contrast Agents with High Relaxivity.Sample Shuttling Relaxometry of Contrast Agents: NMRD Profiles above 1 T with a Single DeviceOptical and relaxometric properties of monometallic (Eu(III), Tb(III), Gd(III)) and heterobimetallic (Re(I)/Gd(III)) systems based on a functionalized bipyridine-containing acyclic ligand.Optimized relaxivity and stability of [Gd(H(2,2)-1,2-HOPO)(H2O)]- for use as an MRI contrast agent.The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.Primer on gadolinium chemistry.Alternatives to gadolinium-based metal chelates for magnetic resonance imagingA new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study.High relaxivity magnetic resonance imaging contrast agents. Part 1. Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexes.Challenges for Molecular Neuroimaging with MRI.Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Synthesis, complexation and NMR relaxation properties of Gd3+ complexes of Mes(DO3A)3.The Gd3+ complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid mono(p-isothiocyanatoanilide) conjugated to inulin: a potential stable macromolecular contrast agent for MRI.Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast
P2860
Q24617694-127F67C8-4BE5-4714-93A8-EAEAE997AEA6Q27683418-C45499E4-A458-4BD8-B7C0-D3F732249135Q28235682-FC84D256-AD54-49C2-A7EB-99ADB392A97DQ28283802-E881DA1E-5FB7-43FE-B18B-D2C00850D4E6Q28535719-3CF7C2E7-04DE-42E3-82BF-C23F43062F70Q28661179-D1691165-B211-4033-BB5F-97A0759FE2D9Q30369301-9C87ABEB-0C09-4F3F-AC66-428DBFB44E6FQ30465976-85B665A5-8A23-4EAC-897E-73AC04861EFAQ30559561-E399C36E-E954-4A91-8E45-E4F74EC59861Q30568297-5DF3A642-0728-497A-8748-9C59B48664FBQ30574482-6B7A37C3-EA9C-4F71-96EB-60FAFDA44A63Q30576125-09FB3058-9A0D-4ECC-A3B5-70549072DEE0Q30583956-6787AEF4-49E8-4391-9D3D-ED8059887A61Q30604750-25C17992-3E88-4521-9698-9276CA572F39Q30659328-087C9266-BA96-402B-A65F-61B75CD344D1Q30667816-FF13F0AB-C7C2-4A82-AEF7-7ADADD801344Q30719947-1110EDC0-5C39-408B-B033-8A9E6ED46202Q30794877-B0004B41-B26A-4BA1-8F77-DAE49BCE96A3Q30807730-9E1155F8-77E0-4AF3-90A4-9C52FFE7A209Q30808459-BD4751D3-A63F-4C52-888F-99B50E890725Q30831013-2FE7B63B-6D54-4D49-8097-30808E53F98BQ30831437-EFA5B27F-B0FB-44A2-9E1B-D8FF1AF95AE1Q30853705-6757D142-E154-4A6B-A3AD-3FC42EFF3EA9Q30891244-54464DD6-22FE-4E17-95FA-283F09904533Q30924405-CEDD3B57-6D24-4C76-9C11-D4CEA1778DD8Q31033559-193DEA15-3BC2-4BC8-BE9C-E947B0C990A2Q31052821-C14A314F-74A0-43FC-A573-7B9E8673065AQ31083784-3744D039-4BB5-45C3-9330-5D864D71B6A2Q31112386-4DDB80C9-12B8-4F23-9AD1-A1B7A5E5F097Q31161095-9D74E578-93EA-4F54-B38C-59654A4B8F11Q33516622-112DE35B-EE12-442D-8F43-374832312D07Q33557361-31E3FA8B-FEA2-4859-9B99-2C60029AAD22Q33614436-FEF495F9-DA36-4F39-AF06-4CEAF77D48FFQ33679689-1A4F739D-359F-4D86-9C20-79CB92B51EBBQ33680025-0FD4B91D-A001-4D1E-B04F-6329BD81A8C3Q33778292-D89C7F18-C35E-4D76-AB14-2CFC9BB6C1E3Q33847006-38B704FA-3C24-4072-8A0F-3E932EA9C692Q33858379-36149BD3-10B7-4138-B431-D73B9A536CB3Q34092267-6CD9B815-7737-4AF8-B75F-14A27034445EQ34145477-2AFE28BE-BAF5-478A-9ED7-041DB5DE3C84
P2860
Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Comparative study of the physi ...... ht gadolinium contrast agents.
@ast
Comparative study of the physi ...... ht gadolinium contrast agents.
@en
type
label
Comparative study of the physi ...... ht gadolinium contrast agents.
@ast
Comparative study of the physi ...... ht gadolinium contrast agents.
@en
prefLabel
Comparative study of the physi ...... ht gadolinium contrast agents.
@ast
Comparative study of the physi ...... ht gadolinium contrast agents.
@en
P2093
P356
P1476
Comparative study of the physi ...... ht gadolinium contrast agents.
@en
P2093
Luce Vander Elst
Robert N Muller
Sophie Laurent
P304
P356
10.1002/CMMI.100
P577
2006-05-01T00:00:00Z